ContextVision AB represents a strong set of values and corporate philosophy. The company is committed to delivering high-quality medical imaging software solutions to healthcare providers worldwide. ContextVision AB prioritizes innovation, collaboration, and customer satisfaction. With a strong focus on research and development, ContextVision AB continuously strives to enhance patient care and improve outcomes. By leveraging cutting-edge technology and expertise, the company aims to provide efficient and reliable solutions for medical image analysis and enhancement. ContextVision AB's commitment to excellence and customer-centric approach make it a trusted leader in the healthcare technology industry.

ContextVision AB is primarily present in several countries and regions. It has a strong presence in Europe, with a focus on Scandinavian countries such as Sweden, Norway, and Finland. The company also operates in other European regions including Germany and the United Kingdom. In addition to Europe, ContextVision AB has expanded its presence in the Asia-Pacific region, particularly in China and Japan. Furthermore, the company has a growing customer base in North America, particularly in the United States and Canada. ContextVision AB's global footprint allows it to cater to a wide range of customers and provide its innovative stock services worldwide.

ContextVision AB has successfully achieved several significant milestones over the years. Some noteworthy accomplishments include developing innovative software solutions for medical imaging, establishing strong partnerships with leading industry players, and receiving numerous prestigious awards for their cutting-edge technologies. Additionally, ContextVision AB has consistently demonstrated strong financial performance and growth, consolidating its position as a key player in the medical imaging market. These milestones highlight the company's commitment to innovation, excellence, and delivering value to its customers. ContextVision AB's achievements emphasize its reputation as a reliable and forward-thinking company in the field of medical imaging.

ContextVision AB is a renowned company specializing in medical imaging software solutions. Established in 1983, the company has amassed a rich history and background in the medical technology domain. ContextVision AB focuses on developing innovative software, such as image enhancement, 3D visualization, and AI-based technologies, catering to healthcare providers and medical imaging equipment manufacturers globally. With its strong industry expertise and continuous research and development efforts, ContextVision AB has positioned itself as a leading provider of state-of-the-art imaging solutions. The company's dedication to quality and customer satisfaction has earned it a reputable name in the medical imaging industry.

The main competitors of ContextVision AB in the market include companies such as GE Healthcare, Siemens Healthineers, and Merge Healthcare. These companies also operate in the medical imaging and artificial intelligence software sectors, offering similar products and solutions. ContextVision AB strives to distinguish itself through its innovative technologies and advanced image enhancement solutions, ensuring enhanced image quality and accurate diagnoses for healthcare professionals. With a strong focus on research and development, ContextVision AB continuously aims to stay ahead of the competition and deliver cutting-edge software solutions to meet the evolving needs of the medical imaging industry.

ContextVision AB is primarily active in the medical imaging industry.

The business model of ContextVision AB is focused on providing advanced medical imaging software solutions. The company develops and sells state-of-the-art image enhancement technologies for use in various medical imaging applications. ContextVision's software algorithms are designed to enhance image quality, optimize accuracy, and improve workflow efficiency. By partnering with leading original equipment manufacturers (OEMs) in the medical imaging industry, ContextVision aims to deliver innovative solutions that enable healthcare providers to obtain clearer and more accurate medical images. With a strong emphasis on research and development, ContextVision continuously strives to maintain its position as a trusted provider of advanced imaging solutions to improve patient care and diagnosis.

ContextVision의 P/E 비율은 17.26입니다.

ContextVision의 P/S 비율은 3.31입니다.

ContextVision에 대한 AlleAktien 품질 점수는 4/10입니다.

예상되는 ContextVision 매출은 136.99 백만 SEK입니다.

예상되는 ContextVision 이익은 26.3 백만 SEK입니다.

ContextVision AB is a leading provider of innovative solutions in the field of medical imaging. The company was founded in 1983 and currently employs over 100 employees. It has been listed on the Nasdaq Stockholm since 1999 and is headquartered in Stockholm, Sweden. ContextVision consists of four business areas that focus on specific segments of medical imaging: digital pathology, ultrasound, mammography, and radiography. Each business area offers a wide range of products and services aimed at improving precision, efficiency, and patient care. The product portfolio of ContextVision is tailored to the needs of medical professionals and clinicians who rely on accurate analysis and diagnosis of images. For example, the company offers a state-of-the-art software platform for digital pathology, allowing pathologists to digitally capture, store, and analyze histological images and data. This improves the accuracy of diagnosis and increases efficiency in pathology laboratories. Another example is the company's ultrasound division, which focuses on improving image quality and precision in ultrasound diagnostics. Through its image enhancement technology, ContextVision provides more productive diagnostic solutions that are faster and more accurate than conventional ultrasound systems. The company also offers solutions for mammography that target the detection of smaller tumors. Together, these offerings not only improve patient care but also contribute to reducing medical errors. ContextVision gains market share through partnerships with leading manufacturers of medical imaging devices. The company leverages its unique expertise in image analysis and enhancement to develop innovative solutions in collaboration with its partners. This collaboration has, for example, led to the development of the "GOPiCE" concept, which represents a benchmark in digital pathology. The range of solutions allows customers to create more efficient diagnoses while ensuring higher accuracy and reliability in patient care. Overall, ContextVision has secured its leading position in the field of medical imaging through the continuity of its performance and its willingness to adapt to the needs of its customers and partners. The company is committed to improving medical imaging and supporting its customers through innovative solutions. ContextVision is a pioneer in image analysis and an important component in the medical field.

ContextVision은(는) 연간 번의 배당을 통해 0 SEK의 배당금을 지급합니다.

ContextVision의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

ContextVision의 ISIN은 SE0014731154입니다.

ContextVision의 WKN은 A2QA6S입니다.

ContextVision의 티커는 CONTX.OL입니다.

지난 12개월 동안 ContextVision은(는) 0.45 SEK 의 배당금을 지급했습니다. 이는 약 7.67 %의 배당 수익률에 해당합니다. 향후 12개월 동안 ContextVision은(는) 0.45 SEK의 배당금을 지급할 것으로 예상됩니다.

ContextVision의 현재 배당 수익률은 7.67 %입니다.

ContextVision은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

ContextVision은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0.45 SEK의 배당금이 예상됩니다. 이는 배당수익률 7.67 %에 해당합니다.

ContextVision은 '건강' 섹터에 속합니다.

ContextVision의 마지막 배당금을 0.15 SEK만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 ContextVision는 0 SEK를 배당금으로 지급했습니다.

ContextVision의 배당금은 SEK에 지급됩니다.